These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study. Song KH; Lee YC; Fan DM; Ge ZZ; Ji F; Chen MH; Jung HC; Bo J; Lee SW; Kim JH Digestion; 2011; 84(3):221-9. PubMed ID: 21757914 [TBL] [Abstract][Full Text] [Related]
3. Effect of rebamipide on Helicobacter pylori infection in patients with peptic ulcer. Nebiki H; Higuchi K; Arakawa T; Ando K; Uchida T; Ito H; Harihara S; Kuroki T; Kobayashi K Dig Dis Sci; 1998 Sep; 43(9 Suppl):203S-206S. PubMed ID: 9753251 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study. Andreev DN; Maev IV; Dicheva DT; Samsonov AA; Partzvania-Vinogradova EV Ter Arkh; 2018 Aug; 90(8):27-32. PubMed ID: 30701936 [TBL] [Abstract][Full Text] [Related]
5. Effect of rebamipide on gastric ulcer healing caused by Helicobacter pylori and/or NSAIDs or non NSAIDs-non H. pylori. Thong-Ngam D; Chayanupatkul M; Klaikeaw N; Rerknimitr R; Mahachai V J Med Assoc Thai; 2009 Sep; 92(9):1207-12. PubMed ID: 19772181 [TBL] [Abstract][Full Text] [Related]
6. A pilot study to evaluate a new combination therapy for gastric ulcer: Helicobacter pylori eradication therapy followed by gastroprotective treatment with rebamipide. Terano A; Arakawa T; Sugiyama T; Yoshikawa T; Haruma K; Asaka M; Shimosegawa T; Sakaki N; Ishii H; Sakamoto C; Takahashi S; Kinoshita Y; Fujioka T; Kobayashi K J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):103-9. PubMed ID: 16706820 [TBL] [Abstract][Full Text] [Related]
7. Effects of rebamipide in combination with lansoprazole and amoxicillin on Helicobacter pylori-infected gastric ulcer patients. Kato M; Asaka M; Sugiyama T; Kudo M; Nishikawa K; Sukegawa M; Hokari K; Katagiri M; Sato F; Kagaya H; Takeda H Dig Dis Sci; 1998 Sep; 43(9 Suppl):198S-202S. PubMed ID: 9753250 [TBL] [Abstract][Full Text] [Related]
8. Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial. Terano A; Arakawa T; Sugiyama T; Suzuki H; Joh T; Yoshikawa T; Higuchi K; Haruma K; Murakami K; Kobayashi K; J Gastroenterol; 2007 Aug; 42(8):690-3. PubMed ID: 17701133 [TBL] [Abstract][Full Text] [Related]
9. Effects of rebamipide, a gastro-protective drug on the Helicobacter pylori status and inflammation in the gastric mucosa of patients with gastric ulcer: a randomized double-blind placebo-controlled multicentre trial. Fujioka T; Arakawa T; Shimoyama T; Yoshikawa T; Itoh M; Asaka M; Ishii H; Kuwayama H; Sato R; Kawai S; Takemoto T; Kobayashi K Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():146-52. PubMed ID: 12925153 [TBL] [Abstract][Full Text] [Related]
10. Rebamipide prevents delay of acetic acid-induced gastric ulcer healing caused by Helicobacter pylori infection in Mongolian gerbils. Watanabe T; Higuchi K; Hamaguchi M; Tanigawa T; Wada R; Tominaga K; Fujiwara Y; Arakawa T Dig Dis Sci; 2002 Jul; 47(7):1582-9. PubMed ID: 12141820 [TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori eradication in the healing and recurrence of benign gastric ulcer: a two-year, double-blind, placebo controlled study. Lazzaroni M; Perego M; Bargiggia S; Maconi G; Fiocca R; Solcia E; Franceschi M; Cesana B; Bianchi Porro G Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):220-7. PubMed ID: 9646213 [TBL] [Abstract][Full Text] [Related]